News and Comments

The Sky’s The Limit For Micromet’s BiTE Technology’s Capability

  Tuesday, July 19, 2011

Micromet (MITI) added another important collaborator, Amgen (AMGN), to a long list of large and small drug developing companies that are attracted to Micromet’s BiTE technology. Amgen/Micromet agreement looks fair for both. It fits Amgen’s strategy of focusing on adding next-generation products to its pipeline and helps Micromet’s financial requirements during the development of its promising proprietary cancer programs. Amgen wanted to select from among three BiTE-based drugs against three undisclosed solid tumor targets. The giant biotech will pay upfront, milestone, and other payments in a deal that could be worth over $900 million for the two selected drugs, or half of this amount if it selects only one drug, in addition to double-digit royalties in the event of approvals and sales. More...

Recent Postings



Vitae Pharmaceuticals (VTAE) Illumina (ILMN) Roche (RHHBY) Prosensa (RNA) ABBVIE (ABBV) Intermune (ITMN) Anadys (ANDS) Agenus (AGEN Sarepta (SRPT) Vertex (VRTX) Idenix (IDIX) ARGOS (ARGS) ADVENTRIX (ANX) Velcade (bortezomib) Xoma (XOMA) NANTKWEST (NK) Bellicum (BLCM) HALOZYME (HALO) ISIS (ISIS) Gilead (GILD) ACADIA (ACAD) Roche (ROCHE) Tysabri REGULUS (RGLS) NEKTAR (NKTR)) PTC Therapeutics (PTCT) Agenus (AGEN) TOKAI (TKAOI) Elan (ELN) ARCA (ABIO) Intrexon (XON) Biocryst (BCRX) ImmunoGen (IMGN) C4 Therapeutics OSI (OSIP) Endometrial Cancer Sanofi (SNA) RenenxBio (RGNX) Multiple Myeloma Dynavax (DVAX) Sanofi-Aventis (SAN) Rapamune Amgen (AMGN) Mirati Therapeutics (MRTX) Zerenex Advaxis (ADXS) Theravance (THRX) GUARDIAN HEALTH Onyx (ONXX) SYNTA (SNTA) KITE (KITE) Micromet (MITI) Global Cell Therapeutics (GBT) Alnylam (ALNY) Alder Biopharmaceuticals (ALDR) Pluristem (PSTI) Prolor Biotech (PBTH) Herceptin Bristol-Myers Squibb (BMY) AERIE PHARMACEUTICALS SERES THERAPEUTICS (MCRB) Sanofi (SNY) VANDA (VNDA) Intercept (ICPT) Genentech Ridaforolimus Valeant Pharmaceuticals International (VRX) Exelixis (EXEL) Editas (EDIT) Incyte (INCY) SUNESIS PHARMACEUTICALS (SNSS) Adaptimmune (ADAP) Human Longevity (HLI) GlaxoSmithKline (GSK) Cytokinetics (CYTK) BIOMARIN (BMRN) Trastuzumab-DM1 Regeneron (REGN) Jazz Pharmaceuticals (JAZZ) Telaprevir ZALTRAP™ AstraZeneca (AZN) Human Genome Sciences (HGSI) Merck (MRK) CompuGen (CGEN) Sangamo (SGMO) Revlimid (lenolidamide) Array Pharmaceuticals (ARRY) JUNO (JUNO) MODERNA Ariad (ARIA) Abbott Laboratories (ABT) INNOVIVA (INVA) Seattle Genetics (SGEN) AGOS (ARGS) Dendreon (DNDN) NOVOCURE (NVCR) Galena (GALE) IDERA (IDRA) CRISPR Therapeutics (CRSP) KERYX (KERX) Aimmune Therapeutics (AIMT) Theravance Bio Pharma (TBPH) Sequenom (SQNM) Ionis (IONS) Auspex (ASPX) Biogen Idec (BIIB) galapagos (GLPG) Spike Therapeutics (ONCE) Benlysta (belimumab) Ziofpharm (ZIOP) Anacor (ANAC) Inovio (INO)